The 2001 serological survey in the Czech Republic--mumps
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
15080260
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Adult MeSH
- Immunoenzyme Techniques MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Child, Preschool MeSH
- Mumps blood epidemiology immunology MeSH
- Antibodies, Viral blood MeSH
- Data Collection MeSH
- Serologic Tests MeSH
- Mumps Vaccine administration & dosage immunology MeSH
- Mumps virus immunology MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Child, Preschool MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic epidemiology MeSH
- Names of Substances
- Antibodies, Viral MeSH
- Mumps Vaccine MeSH
In total, 3,010 sera from a representative population sample of the Czech Republic aged from 1 to 64 years were tested according to the requirements of the ESEN 2 project using a commercial kit Mumps IgG (II) EIA manufactured by Denka Seiken, Japan. To date, the regular programme of vaccination against mumps has covered the population of children under 15 years of age. The vaccination coverage achieved (97-100%) does not correspond to the antibody prevalence rates of 70.2 to 86.4% as found. After implementation of regular vaccination in 1987, the morbidity rates have fallen dramatically. Nevertheless, the collective immunity achieved is not sufficient to prevent epidemics of mumps.
